Literature DB >> 21531875

Type II Toxoplasma gondii KU80 knockout strains enable functional analysis of genes required for cyst development and latent infection.

Barbara A Fox1, Alejandra Falla, Leah M Rommereim, Tadakimi Tomita, Jason P Gigley, Corinne Mercier, Marie-France Cesbron-Delauw, Louis M Weiss, David J Bzik.   

Abstract

Type II Toxoplasma gondii KU80 knockouts (Δku80) deficient in nonhomologous end joining were developed to delete the dominant pathway mediating random integration of targeting episomes. Gene targeting frequency in the type II Δku80 Δhxgprt strain measured at the orotate (OPRT) and the uracil (UPRT) phosphoribosyltransferase loci was highly efficient. To assess the potential of the type II Δku80 Δhxgprt strain to examine gene function affecting cyst biology and latent stages of infection, we targeted the deletion of four parasite antigen genes (GRA4, GRA6, ROP7, and tgd057) that encode characterized CD8(+) T cell epitopes that elicit corresponding antigen-specific CD8(+) T cell populations associated with control of infection. Cyst development in these type II mutant strains was not found to be strictly dependent on antigen-specific CD8(+) T cell host responses. In contrast, a significant biological role was revealed for the dense granule proteins GRA4 and GRA6 in cyst development since brain tissue cyst burdens were drastically reduced specifically in mutant strains with GRA4 and/or GRA6 deleted. Complementation of the Δgra4 and Δgra6 mutant strains using a functional allele of the deleted GRA coding region placed under the control of the endogenous UPRT locus was found to significantly restore brain cyst burdens. These results reveal that GRA proteins play a functional role in establishing cyst burdens and latent infection. Collectively, our results suggest that a type II Δku80 Δhxgprt genetic background enables a higher-throughput functional analysis of the parasite genome to reveal fundamental aspects of parasite biology controlling virulence, pathogenesis, and transmission.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21531875      PMCID: PMC3187049          DOI: 10.1128/EC.00297-10

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  66 in total

1.  Differential membrane targeting of the secretory proteins GRA4 and GRA6 within the parasitophorous vacuole formed by Toxoplasma gondii.

Authors:  E Labruyere; M Lingnau; C Mercier; L D Sibley
Journal:  Mol Biochem Parasitol       Date:  1999-08-20       Impact factor: 1.759

2.  Stable transformation of Toxoplasma gondii based on a pyrimethamine resistant trifunctional dihydrofolate reductase-cytosine deaminase-thymidylate synthase gene that confers sensitivity to 5-fluorocytosine.

Authors:  B A Fox; A A Belperron; D J Bzik
Journal:  Mol Biochem Parasitol       Date:  1999-01-05       Impact factor: 1.759

3.  Disruption of the Toxoplasma gondii bradyzoite-specific gene BAG1 decreases in vivo cyst formation.

Authors:  Y W Zhang; K Kim; Y F Ma; M Wittner; H B Tanowitz; L M Weiss
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501

Review 4.  Sabotage and exploitation in macrophages parasitized by intracellular protozoans.

Authors:  Eric Y Denkers; Barbara A Butcher
Journal:  Trends Parasitol       Date:  2005-01

5.  Stage conversion of Toxoplasma gondii in mouse brain during infection and immunodepression.

Authors:  H Odaert; M Soête; B Fortier; D Camus; J F Dubremetz
Journal:  Parasitol Res       Date:  1996       Impact factor: 2.289

6.  Insertional tagging, cloning, and expression of the Toxoplasma gondii hypoxanthine-xanthine-guanine phosphoribosyltransferase gene. Use as a selectable marker for stable transformation.

Authors:  R G Donald; D Carter; B Ullman; D S Roos
Journal:  J Biol Chem       Date:  1996-06-14       Impact factor: 5.157

7.  Sequential protein secretion from three distinct organelles of Toxoplasma gondii accompanies invasion of human fibroblasts.

Authors:  V B Carruthers; L D Sibley
Journal:  Eur J Cell Biol       Date:  1997-06       Impact factor: 4.492

8.  Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis.

Authors:  D K Howe; S Honoré; F Derouin; L D Sibley
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

9.  Targeted disruption of the GRA2 locus in Toxoplasma gondii decreases acute virulence in mice.

Authors:  C Mercier; D K Howe; D Mordue; M Lingnau; L D Sibley
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

10.  Targeted disruption of the bradyzoite-specific gene BAG1 does not prevent tissue cyst formation in Toxoplasma gondii.

Authors:  W Bohne; C A Hunter; M W White; D J Ferguson; U Gross; D S Roos
Journal:  Mol Biochem Parasitol       Date:  1998-05-01       Impact factor: 1.759

View more
  85 in total

1.  The state of research for AIDS-associated opportunistic infections and the importance of sustaining smaller research communities.

Authors:  Anthony P Sinai; Edna S Kaneshiro; Honorine Ward; Louis M Weiss; Melanie T Cushion
Journal:  Eukaryot Cell       Date:  2011-12-09

2.  Acridones Are Highly Potent Inhibitors of Toxoplasma gondii Tachyzoites.

Authors:  P Holland Alday; Erin V McConnell; Jan M Boitz Zarella; Rozalia A Dodean; Papireddy Kancharla; Jane X Kelly; J Stone Doggett
Journal:  ACS Infect Dis       Date:  2021-03-16       Impact factor: 5.084

3.  An improved method for introducing site-directed point mutation into the Toxoplasma gondii genome using CRISPR/Cas9.

Authors:  Tatsuki Sugi; Kentaro Kato; Louis M Weiss
Journal:  Parasitol Int       Date:  2016-05-07       Impact factor: 2.230

4.  AMA1-deficient Toxoplasma gondii parasites transiently colonize mice and trigger an innate immune response that leads to long-lasting protective immunity.

Authors:  Vanessa Lagal; Márcia Dinis; Dominique Cannella; Daniel Bargieri; Virginie Gonzalez; Nicole Andenmatten; Markus Meissner; Isabelle Tardieux
Journal:  Infect Immun       Date:  2015-04-06       Impact factor: 3.441

Review 5.  Toxoplasma Effectors Targeting Host Signaling and Transcription.

Authors:  Mohamed-Ali Hakimi; Philipp Olias; L David Sibley
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

6.  Transcriptomic analysis reveals Toxoplasma gondii strain-specific differences in host cell response to dense granule protein GRA15.

Authors:  Qing Liu; Wen-Wei Gao; Hany M Elsheikha; Jun-Jun He; Fa-Cai Li; Wen-Bin Yang; Xing-Quan Zhu
Journal:  Parasitol Res       Date:  2018-06-19       Impact factor: 2.289

Review 7.  Strategies to discover the structural components of cyst and oocyst walls.

Authors:  John Samuelson; G Guy Bushkin; Aparajita Chatterjee; Phillips W Robbins
Journal:  Eukaryot Cell       Date:  2013-10-04

8.  Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour?

Authors:  Joanne P Webster; Maya Kaushik; Greg C Bristow; Glenn A McConkey
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

9.  The Toxoplasma nuclear factor TgAP2XI-4 controls bradyzoite gene expression and cyst formation.

Authors:  Robert Walker; Mathieu Gissot; Matthew M Croken; Ludovic Huot; David Hot; Kami Kim; Stanislas Tomavo
Journal:  Mol Microbiol       Date:  2012-12-26       Impact factor: 3.501

10.  Secreted protein kinases regulate cyst burden during chronic toxoplasmosis.

Authors:  Nathaniel G Jones; Qiuling Wang; L David Sibley
Journal:  Cell Microbiol       Date:  2016-08-25       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.